TETRA Technologies, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- TETRA Technologies, Inc. (NYSE: TTI) provides specialized solutions to the energy and industrial sectors. The company manufactures and sells completion fluids, calcium chloride, brominated products; water management services, including onshore produced water recycling, lithium extraction from brines; and performance chemicals for oil and gas well completions, industrial applications. TETRA Technologies operates globally, with facilities in North America, Europe, and Latin America, targeting upstream energy producers, industrial manufacturers, and water management firms. Founded in 1981 and headquartered in The Woodlands, Texas, the company serves the oilfield services industry through its Water and Flowback Services, Completion Fluids and Products, and Performance Chemicals segments. It holds a leading position in clear brine fluids used in drilling and completions worldwide. In recent developments, TETRA Technologies expanded its lithium production capabilities with the commercial launch of its Phase 1A direct lithium extraction facility from produced water in Q1 2025; formed strategic alliances for sustainable water recycling technologies; and completed a $100 million funding round in late 2024 to support direct air capture and critical minerals initiatives. The company also acquired select assets from a competitor to bolster its bromine-based products portfolio in 2024. These moves reflect a strategic shift toward low-carbon energy transition services and diversification beyond traditional oilfield chemicals.
Company News
Thiogenesis Engages Brisco Capital for Investor Relations
TETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
Technip Energies (OTCMKTS:THNPY) versus Tetra Technologies (NYSE:TTI) Critical Contrast
Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript
Tetra Technologies Q2 Earnings Call Highlights
Tetra Technologies (TTI) Reports Q2 Earnings: What Key Metrics Have to Say
TETRA Technologies, Inc. (TTI) Q2 2026 Earnings Call Transcript
Tetra Technologies (TTI) Q2 Earnings Meet Estimates
Compared to Estimates, Tetra Technologies (TTI) Q2 Earnings: A Look at Key Metrics
TETRA TECHNOLOGIES, INC. REPORTS STRONG SECOND-QUARTER 2026 RESULTS
Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109
Tetra Technologies (TTI) to Report Q2 Results: What to Know Ahead of the Release
TETRA TECHNOLOGIES, INC. ANNOUNCES DATE FOR SECOND QUARTER 2026 EARNINGS CONFERENCE CALL
Thiogenesis Receives FDA Rare Pediatric Disease Designation for TTI-0102 for the Treatment of Leigh Syndrome
Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement Transcript
Tvardi Therapeutics' TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement
Tetra Technologies (TTI) Soars 6.6%: Is Further Upside Left in the Stock?
TETRA TECHNOLOGIES INTRODUCES TETRA NEPTUNE Z-LITE DEEPWATER COMPLETIONS FLUID
TETRA Technologies, Inc. (TTI) Presents at J.P. Morgan Natural Resources Conference 2026 Transcript
Thiogenesis Appoints Dr. Gilad Aharon to Its Board of Directors